Comparison Chart Finch Therapeutics Group, Inc.

Stocks

FNCHQ

US31773D2009

Biotechnology & Medical Research

Market Closed - OTC Markets 13:02:58 2026-05-18 EDT			5-day change	1st Jan Change
7.750 ^USD	+6.90%		-23.27%	-42.54%

04-26	Acurx Pharmaceuticals, Inc., Adiso Therapeutics, Inc., Summit Therapeutics Inc., Finch Therapeutics Group, Inc. and Astrazeneca plc Announces Clostridium Difficile Infections Clinical Trial Updates	CI
03-26	Motion for Joint Administration Approved for Finch Therapeutics Group, Inc.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	FINCH THERAPEUTICS GROUP, INC.	Other Biotechnology & Medical Research	+6.90%	-23.27%	-42.54%	-36.21%	-98.04%	16.22M	-	-	-